- Home
- IMUX vs STRW Comparison
IMUX vs STRW Comparison
Compare IMUX & STRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMUX | STRW |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | United States | United States |
| Employees | 66 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.6M | 176.3M |
| IPO Year | 2013 | 2019 |
Fundamental Metrics
Financial Performance| Metric | IMUX | STRW |
|---|---|---|
| Price | $11.65 | $13.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $36.00 | $13.88 |
| AVG Volume (30 Days) | ★ 2.1M | 13.4K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 5.17% |
| EPS Growth | ★ 38.00 | 5.26 |
| EPS | N/A | ★ 0.60 |
| Revenue | N/A | ★ $154,999,000.00 |
| Revenue This Year | N/A | $8.52 |
| Revenue Next Year | N/A | $3.95 |
| P/E Ratio | ★ N/A | $21.67 |
| Revenue Growth | N/A | ★ 32.41 |
| 52 Week Low | $0.51 | $9.46 |
| 52 Week High | $11.33 | $14.00 |
Technical Indicators
Market Signals| Indicator | IMUX | STRW |
|---|---|---|
| Relative Strength Index (RSI) | 86.19 | 56.13 |
| Support Level | $0.75 | $12.51 |
| Resistance Level | N/A | $13.46 |
| Average True Range (ATR) | 0.73 | 0.43 |
| MACD | 0.73 | 0.05 |
| Stochastic Oscillator | 99.54 | 84.13 |
Price Performance
Historical ComparisonAbout IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.
About STRW Strawberry Fields REIT Inc.
Strawberry Fields REIT Inc is a self-managed and self-administered company that specializes in the acquisition, ownership and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties.